placeholder image
J. L. Probstfield uri icon qr icon All authors
About me
Publications
selected publications
Journal Article
  • Design of FLAT-SUGAR: randomized trial of prandial insulin versus prandial GLP-1 receptor agonist together with basal insulin and metformin for high-risk type 2 diabetes
    Diabetes care. 2015
  • Author response to lipid-lowering in African Americans in ALLHAT-optimism bias?
    Journal of Clinical Hypertension (Greenwich, Conn.). 2013
  • Long-term follow-up of moderately hypercholesterolemic hypertensive patients following randomization to pravastatin vs usual care: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT-LLT)
    Journal of Clinical Hypertension (Greenwich, Conn.). 2013
  • Mortality and morbidity during and after Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial: results by sex
    Hypertension (Dallas, Tex.. 2013
  • Combined intensive blood pressure and glycemic control does not produce an additive benefit on microvascular outcomes in type 2 diabetic patients
    Kidney International. 2012
  • Long-term effects of intensive glucose lowering on cardiovascular outcomes
    New England Journal of Medicine. 2011
  • Effects of intensive blood-pressure control in type 2 diabetes mellitus
    New England Journal of Medicine. 2010
  • ALLHAT findings revisited in the context of subsequent analyses, other trials, and meta-analyses
    Archives of Internal Medicine. 2009
  • Coronary heart disease in moderately hypercholesterolemic, hypertensive black and non-black patients randomized to pravastatin versus usual care: the antihypertensive and lipid lowering to prevent heart attack trial (ALLHAT-LLT)
    American Heart Journal. 2009
  • Effects of intensive glucose lowering in type 2 diabetes
    New England Journal of Medicine. 2008
  • Contact
    full name
  • J. L. Probstfield
  • JL Probstfield
  • Quick Info
     
    Collaboration